| Status: Excluded due to NICE appraisal | |
Product meets AWMSG exclusion criteria due to NICE appraisal TA973: Atogepant for preventing migraine |
|
Medicine details |
|
| Medicine name | atogepant (Aquipta®) |
| Formulation | oral |
| Reference number | 3689 |
| Indication | Prophylaxis of episodic migraine |
| Company | Allergan Ltd |
| BNF chapter | Central nervous system |
| Assessment type | N/A |
| Status | Excluded due to NICE appraisal |
| Date of issue | 21/03/2024 |
| NICE guidance | |